Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Francque

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
The American Journal of Gastroenterology|March 19, 2024
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver DiseaseEmma Vanderschueren, Angelo Armandi, Wilhelmus Kwanten, et al.
Acta Gastro-Enterologica Belgica|December 30, 2015
Validation of APRI and FIB-4 score in an Antwerp cohort of chronic hepatitis C patientsWim Verlinden, Stefan Bourgeois, Marc De Maeyer, et al.
Plos One|November 25, 2015
Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic FeaturesLuisa Vonghia, Thea Magrone, An Verrijken, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 7, 2016
Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected PatientsWim Verlinden, Stefan Bourgeois, Pierre Gigase, et al.
Minerva Chirurgica|February 16, 2017
Innovative molecular targeted agents in hepatocellular carcinoma: new gladiators on the arenaJose Ferri, Yanina Dockx, Luisa Vonghia, et al.
World Journal of Hepatology|October 11, 2021
Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in CambodiaAnja De Weggheleire, Jozefien Buyze, Sokkab An, et al.
Nature Reviews. Gastroenterology & Hepatology|June 17, 2022
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weightMohammed Eslam, Hashem B El-Serag, Sven Francque, et al.
European Journal of Gastroenterology & Hepatology|March 11, 2011
Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosisSven Francque, An Verrijken, Ilse Mertens, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 19, 2016
Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?Thiery Chapelle, Bart Op De Beeck, Ivan Huyghe, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2019
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesityPhilip Newsome, Sven Francque, Stephen Harrison, et al.
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
The American Journal of Gastroenterology|March 19, 2024
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver DiseaseEmma Vanderschueren, Angelo Armandi, Wilhelmus Kwanten, et al.
Acta Gastro-Enterologica Belgica|December 30, 2015
Validation of APRI and FIB-4 score in an Antwerp cohort of chronic hepatitis C patientsWim Verlinden, Stefan Bourgeois, Marc De Maeyer, et al.
Plos One|November 25, 2015
Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic FeaturesLuisa Vonghia, Thea Magrone, An Verrijken, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 7, 2016
Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected PatientsWim Verlinden, Stefan Bourgeois, Pierre Gigase, et al.
Minerva Chirurgica|February 16, 2017
Innovative molecular targeted agents in hepatocellular carcinoma: new gladiators on the arenaJose Ferri, Yanina Dockx, Luisa Vonghia, et al.
World Journal of Hepatology|October 11, 2021
Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in CambodiaAnja De Weggheleire, Jozefien Buyze, Sokkab An, et al.
Nature Reviews. Gastroenterology & Hepatology|June 17, 2022
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weightMohammed Eslam, Hashem B El-Serag, Sven Francque, et al.
European Journal of Gastroenterology & Hepatology|March 11, 2011
Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosisSven Francque, An Verrijken, Ilse Mertens, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 19, 2016
Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?Thiery Chapelle, Bart Op De Beeck, Ivan Huyghe, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2019
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesityPhilip Newsome, Sven Francque, Stephen Harrison, et al.
Pageof 18